167 related articles for article (PubMed ID: 18221024)
1. Older and new formulations of cladribine. Pharmacology and clinical efficacy in hematological malignancies.
Robak T; Korycka A; Robak E
Recent Pat Anticancer Drug Discov; 2006 Jan; 1(1):23-38. PubMed ID: 18221024
[TBL] [Abstract][Full Text] [Related]
2. Recent clinical trials of cladribine in hematological malignancies and autoimmune disorders.
Robak T; Wierzbowska A; Robak E
Rev Recent Clin Trials; 2006 Jan; 1(1):15-34. PubMed ID: 18393777
[TBL] [Abstract][Full Text] [Related]
3. Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity.
Robak T; Lech-Maranda E; Korycka A; Robak E
Curr Med Chem; 2006; 13(26):3165-89. PubMed ID: 17168705
[TBL] [Abstract][Full Text] [Related]
4. [Cladribine].
Ogura M
Gan To Kagaku Ryoho; 2003 Feb; 30(2):309-17. PubMed ID: 12610885
[TBL] [Abstract][Full Text] [Related]
5. Beyond hairy cell: the activity of cladribine in other hematologic malignancies.
Sigal DS; Miller HJ; Schram ED; Saven A
Blood; 2010 Oct; 116(16):2884-96. PubMed ID: 20634380
[TBL] [Abstract][Full Text] [Related]
6. [Clinical pharmacology of 2-chlorodeoxyadenosine (Cladribine)].
Góra-Tybor J; Robak T
Przegl Lek; 1996; 53(8):614-8. PubMed ID: 8999463
[TBL] [Abstract][Full Text] [Related]
7. Cladribine: not just another purine analogue?
Spurgeon S; Yu M; Phillips JD; Epner EM
Expert Opin Investig Drugs; 2009 Aug; 18(8):1169-81. PubMed ID: 19604118
[TBL] [Abstract][Full Text] [Related]
8. Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications.
Robak T; Korycka A; Kasznicki M; Wrzesien-Kus A; Smolewski P
Curr Cancer Drug Targets; 2005 Sep; 5(6):421-44. PubMed ID: 16178817
[TBL] [Abstract][Full Text] [Related]
9. Cladribine in the treatment of chronic lymphocytic leukemia.
Robak T
Leuk Lymphoma; 2001 Feb; 40(5-6):551-64. PubMed ID: 11426528
[TBL] [Abstract][Full Text] [Related]
10. [Hairy cell leukemia therapy by cladribine].
Ogura M
Nihon Rinsho; 2004 Jul; 62(7):1337-42. PubMed ID: 15283153
[TBL] [Abstract][Full Text] [Related]
11. On the phosphorylation of 2-chlorodeoxyadenosine (CdA) and its correlation with clinical response in leukemia treatment.
Arnér ES
Leuk Lymphoma; 1996 Apr; 21(3-4):225-31. PubMed ID: 8726403
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group.
Tobinai K; Ogura M; Hotta T; Kobayashi Y; Narabayashi M; Suzuki R; Kinoshita T; Kozuru M; Uike N; Ohashi Y
Jpn J Clin Oncol; 1997 Jun; 27(3):146-53. PubMed ID: 9255268
[TBL] [Abstract][Full Text] [Related]
13. Revisiting the role of cladribine in acute myeloid leukemia: an improvement on past accomplishments or more old news?
Freyer CW; Gupta N; Wetzler M; Wang ES
Am J Hematol; 2015 Jan; 90(1):62-72. PubMed ID: 25284482
[TBL] [Abstract][Full Text] [Related]
14. Purine nucleoside analogues in the treatment of myleoid leukemias.
Robak T
Leuk Lymphoma; 2003 Mar; 44(3):391-409. PubMed ID: 12688309
[TBL] [Abstract][Full Text] [Related]
15. Older and new purine nucleoside analogs for patients with acute leukemias.
Robak P; Robak T
Cancer Treat Rev; 2013 Dec; 39(8):851-61. PubMed ID: 23566572
[TBL] [Abstract][Full Text] [Related]
16. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.
Robak T; Błasińska-Morawiec M; Błoński J; Hellmann A; Hałaburda K; Konopka L; Kotlarek-Haus S; Potoczek S; Hansz J; Dmoszyńska A; Urasiński I; Zdziarska B; Dwilewicz-Trojaczek J; Hołowiecki J; Skotnicki AB
Eur J Haematol; 1999 Jan; 62(1):49-56. PubMed ID: 9918312
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study.
von Rohr A; Schmitz SF; Tichelli A; Hess U; Piguet D; Wernli M; Frickhofen N; Konwalinka G; Zulian G; Ghielmini M; Rufener B; Racine C; Fey MF; Cerny T; Betticher D; Tobler A;
Ann Oncol; 2002 Oct; 13(10):1641-9. PubMed ID: 12377655
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic study of oral and bolus intravenous 2-chlorodeoxyadenosine in patients with malignancy.
Saven A; Cheung WK; Smith I; Moyer M; Johannsen T; Rose E; Gollard R; Kosty M; Miller WE; Piro LD
J Clin Oncol; 1996 Mar; 14(3):978-83. PubMed ID: 8622049
[TBL] [Abstract][Full Text] [Related]
19. Purine analogs in the treatment of chronic lymphocytic leukemia.
Pott C; Hiddemann W
Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834
[TBL] [Abstract][Full Text] [Related]
20. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias.
Cheson BD; Vena DA; Barrett J; Freidlin B
J Clin Oncol; 1999 Aug; 17(8):2454-60. PubMed ID: 10561309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
